Bliss GVS Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2025 ,inter alia, to consider and approve Update on board meeting- To ....
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bliss GVS Pharma has informed the stock exchanges that its Board of Directors will meet on May 12, 2025, to consider and approve the issuance of Sweat Equity Shares to Key Managerial Personnel, Senior Management Personnel, and/or employees of the company. The Board will also determine the issue price, subject to shareholder and regulatory approvals. Sweat equity shares are typically allotted at a discount or for non-cash consideration as part of employee incentive schemes. The trading window for designated persons has been closed since April 1, 2025, and will reopen 48 hours after the Board meeting concludes.
This is a retention and employee incentive move rather than a capital raise from the market. Existing shareholders may see some dilution once the shares are issued, but the impact is usually limited and is generally viewed positively as it aligns management and employee interests with shareholders.